1 story in the last 7 days
The latest vedana therapeutics news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks vedana therapeutics across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Vedana Therapeutics raised $46 million in Series A funding. The financing will support the company's development of small molecule therapies targeting neurodegenerative diseases. The round was led by a syndicate of healthcare investors.
Summaries by ByteBrief